DekaBank Deutsche Girozentrale Raises Stock Holdings in Chemed Corporation $CHE

DekaBank Deutsche Girozentrale raised its holdings in shares of Chemed Corporation (NYSE:CHE) by 0.4% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 155,267 shares of the company’s stock after purchasing an additional 688 shares during the quarter. DekaBank Deutsche Girozentrale owned 1.06% of Chemed worth $75,604,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Renasant Bank boosted its stake in shares of Chemed by 2.3% during the 1st quarter. Renasant Bank now owns 815 shares of the company’s stock valued at $501,000 after buying an additional 18 shares during the last quarter. Cim LLC raised its holdings in Chemed by 1.0% in the first quarter. Cim LLC now owns 2,029 shares of the company’s stock valued at $1,248,000 after acquiring an additional 21 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in Chemed by 16.1% during the 1st quarter. First Horizon Advisors Inc. now owns 173 shares of the company’s stock valued at $107,000 after acquiring an additional 24 shares during the last quarter. Cynosure Group LLC boosted its stake in Chemed by 4.3% during the 1st quarter. Cynosure Group LLC now owns 581 shares of the company’s stock valued at $358,000 after acquiring an additional 24 shares during the last quarter. Finally, Brogan Financial Inc. grew its holdings in Chemed by 7.3% during the 1st quarter. Brogan Financial Inc. now owns 426 shares of the company’s stock worth $262,000 after acquiring an additional 29 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director George J. Walsh III purchased 200 shares of the company’s stock in a transaction on Monday, August 4th. The shares were bought at an average price of $417.10 per share, for a total transaction of $83,420.00. Following the completion of the purchase, the director owned 3,523 shares of the company’s stock, valued at $1,469,443.30. This trade represents a 6.02% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Patrick P. Grace sold 150 shares of Chemed stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the sale, the director directly owned 3,397 shares in the company, valued at approximately $1,574,135.83. This trade represents a 4.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,162 shares of company stock worth $5,677,511 in the last 90 days. 3.29% of the stock is currently owned by insiders.

Chemed Stock Down 0.7%

Shares of NYSE:CHE opened at $441.75 on Wednesday. The company has a market cap of $6.44 billion, a PE ratio of 22.71, a P/E/G ratio of 2.59 and a beta of 0.43. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60. The firm has a 50-day simple moving average of $449.11 and a 200 day simple moving average of $501.36.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts’ consensus estimates of $6.02 by ($1.75). The company had revenue of $618.80 million during the quarter, compared to analyst estimates of $650.60 million. Chemed had a net margin of 11.56% and a return on equity of 25.83%. The business’s revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, research analysts forecast that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 11th were issued a $0.60 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Monday, August 11th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio is 12.34%.

Analyst Ratings Changes

CHE has been the topic of a number of recent analyst reports. Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and upped their target price for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Bank of America cut their price objective on Chemed from $610.00 to $595.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Oppenheimer reduced their target price on Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Finally, Royal Bank Of Canada decreased their target price on Chemed from $640.00 to $589.00 and set an “outperform” rating for the company in a research report on Thursday, July 31st. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $578.50.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.